Clinical Trial Update: Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Carbidopa/Levodopa/Entacapone vs immediate-release Carbidopa/Levodopa in Parkinson's disease patients with non-motor wearing-off symptom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Carbidopa/Levodopa (Immediate Release) (carbidopa/levodopa IR)
• Carbidopa/levodopa/entacapone (carbidopa; levodopa; entacapone)

Snippet

Sponsor: Novartis | Conditions: Parkinson's Disease | Phase 4 | Status: TERMINATED | Results posted: 2011-01-11